Article

Sivaprasad, S., Vasconcelos, J. C., Prevost, A. T., Holmes, H., Hykin, P., George, S., Murphy, C., Kelly, J., Arden, G. B., Ahfat, F., Bhatnagar, A., Narendran, N., Chavan, R., Cole, A., Crosby-Nwaobi, R., Patrao, N., Menon, D., Hogg, C., Rubin, G., Leitch-Devlin, L., Egan, C., Shah, N., Mansour, T., Peto, T., Eleftheriadis, H., Gibson, J., Ghulakhszian, A., Vafidis, G., Hughes, E., Jafree, A., Menon, G., Prakash, P., Sandinha, M., Smith, R., Scanlon, P., Chave, S., Aldington, S., Dale, A., Hood, G., Hitman, G. A., Crabb, D. P. ORCID: 0000-0001-8754-3902, Denniston, A., Lewin, D., Grierson, I., Walker, S., Sturt, J. and Sahu, D. (2018). Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial. The Lancet Diabetes and Endocrinology, 6(5), pp. 382-391. doi: 10.1016/S2213-8587(18)30036-6